Traws Pharma, Inc. Proceeds from Issuance of Warrants
Traws Pharma, Inc. (TRAW) reported Proceeds from Issuance of Warrants of $9.00 million for the 1-month period ending 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2021-03-18
- 2019-12-31: Proceeds from Issuance of Warrants $9.00M; Proceeds from Issuance of Warrants 1 month $9.00M.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 1 month |
|---|---|---|
| 2019-12-31 | $9.00M 10-K · filed 2021-03-18 | $9.00M 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |